Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Chimerix (CMRX) reported a Q3 loss of $0.26 per share, missing the Zacks Consensus Estimate of a $0.24 loss. This is a slight improvement from the $0.27 loss per share a year ago.
November 07, 2024 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chimerix reported a Q3 loss of $0.26 per share, which was worse than the expected loss of $0.24 per share. This may negatively impact the stock price in the short term.
The reported loss per share was worse than expected, which typically leads to a negative reaction in the stock market. Although the loss is slightly better than last year's, missing estimates can still result in a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100